Herrera CMY, de la Rosa GE, Arenas R, Moreno CG

Language: Spanish
References: 17
Page: 15-19
PDF size: 190.62 Kb.

ABSTRACT

Background: tinea corporis is a common mycosis caused by dermatophytes, mainly by the genera Trichophyton, Microsporum, Epidermophyton and Nannizzia.
Patients and methods: an observational and retrospective study including patient’s records with suspected ringworm, referred to the mycology section at Dr. Manuel Gea González General Hospital, from 2013 to 2022.
Objective: to describe epidemiological, clinical and mycological features.
Results: tinea corporis was confirmed in 264 cases, and etiological agent was determined in 94. The affected regions were the torse (48.9%), lower limbs (31.9%), upper limbs (26.5%), face and neck (8.5%). Females were affected in 56.3%. The most impacted age group were adults between 36 and 64 years old. The etiological agents were T. rubrum (61.7%), T. tonsurans (13.8%), and M. canis (9.5%).
Conclusions: T. rubrum remains the most common causative agent in tinea corporis, mainly affecting females and in the torse.

REFERENCES

1. Ajello L, Natural history of the dermatophytes and related fungi,Micopathologia et Mycologia Applicata 1974; 53:93-100.

2. Cabañes FJ. Dermatophytes: the names are a-changin, RevIberoam Micol 2020; 37(1):1-2.

3. Lekkas D, Ioannides D, Lazaridou E, Lallas A, Apalla Z, VakirlisE, Johr R, Errichetti E, Kyrgidis A y Sotiriou E, Dermatoscopy oftinea corporis, jeadv 2020; 34(6):e241-90.

4. Ely JW, Rosenfeld S y Seabury Stone M, Diagnosis and managementof tinea infections, Am Fam Physician 2014; 90:702-10.

5. Arenas R, Dermatofitosis en México, Rev Iberoam Micol 2002;19:63-7.

6. Lachlan JW, Dev T y Rakesh S, Neonatal tinea corporis, mja2017; 207(8):324.

7. Guevara-Cervantes JF, Marioni-Manríquez S, Tello-Ibáñez OO,Vega CD, Vásquez del Mercado E, Rodríguez-Cerdeira C y ArenasR, Tinea corporis. Estudio micológico y epidemiológico de357 casos, Dermatología cmq 2015; 13(4):282-8.

8. Suzuki T, Sato T, Kasuya A y Yaguchi T, A case of tinea faciei, tineacorporis and tinea unguium with dermatophytoma successfullytreated with oral fosravuconazole L-lysine ethanolate, Med Mycol2021; 62:1-4.

9. Lammoglia-Ordiales L, Martínez-Herrera E, Toussaint-Caire S,Arenas R y Moreno-Coutiño G, Tiña incógnita y granuloma deMajocchi adquirido de un erizo. Un caso mexicano, Rev Chil Infectol2018; 35(2):204-6.

10. Chen E, Ghannoum M y Elewski BE, Treatment resistant tineacorporis, a potential public health issue, Br J Dermatol 2021;184(1):164-5.

11. Kruithoff C, Gamal A, McCormick T y Ghannoum MA, Dermatophyteinfections worldwide: increase in incidence and associatedantifungal resistance, Life 2024; 14(1):e1-13.

12. Bhatia A, Kanish B, Badyal DK, Kate P y Choudhary S, Efficacyof oral terbinafine versus itraconazole in treatment of dermatophyticinfection of skin. A prospective, randomized comparativestudy, Indian J Pharmacol 2019; 51:116-9.

13. Lal NR, Basu D, Saha A, Ghosh R, Verma R y Bandyopadhyay D,Efficacy and safety of 250 mg versus 500 mg oral terbinafinein the treatment of tinea corporis and cruris: a randomised, assessor-blinded comparative study, Indian J Dermatol VenereolLeprol 2023; 89:665-71.

14. Dellière S, Joannard B, Benderdouche M, Mingui A, Gits-MuselliM, Hamane S, Alanio A, Petit A, Gabison G, Bagot M y BretagneS, Emergence of difficult to treat tinea corporis caused byTrichophyton mentagrophytes complex isolates, Paris, France,Emerg Infect Dis 2022; 28:224-8.

15. Dell’Antonia M, Mugheddu C, Ala L, Lai D, Pilloni L, Ferreli C yAtzori L, Dermoscopy of tinea incognito, Mycopathologia 2023;188:417-8.

16. Sonthalia S, Ankad BS, Goldust M y Kumar Jha A, Dermoscopy:a single and rapid in vivo diagnostic technique for tinea incognito,An Bras Dermatol 2019; 94(5):612-4.

17. Picone V, Gallo L, Fabbrocini G y Martora F, Impact of covid-19pandemic and the use of telemedicine on the diagnosis andtreatment of tinea corporis: an experience of Southern Italycenter, Dermatol Ther 2022; 35:e15789.